Healthcare Triangle (HCTI) Stock Forecast, Price Target & Predictions


OverviewRevenueOwnershipFinancialsChart

HCTI Stock Forecast


Healthcare Triangle stock forecast is as follows: a rating consensus of 'Buy', based on 1 wall street analysts offering a 1-year stock forecast.

HCTI Analyst Ratings


Buy

According to 1 Wall Street analysts, Healthcare Triangle's rating consensus is 'Buy'. The analyst rating breakdown for HCTI stock is 0 'Strong Buy' (0.00%), 1 'Buy' (100.00%), 0 'Hold' (0.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).

Analyst Ratings Upgrades/Downgrades


DateCompanyPrevious RatingNew RatingRating Change
Sep 28, 2022EF HuttonBuyBuyHold
Row per page
Go to

Healthcare Triangle's last stock rating was published by EF Hutton on Sep 28, 2022. The company gave HCTI a "Buy" rating, the same as its previous rate.

Healthcare Triangle Financial Forecast


Healthcare Triangle Revenue Forecast

Sep 24Jun 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22
Revenue---$7.78M$8.53M$9.84M$11.29M$11.95M$11.59M$11.06M
Avg Forecast$2.41M$2.98M$14.80M$14.50M$13.60M$12.90M$12.40M$12.60M$11.70M$10.40M
High Forecast$2.41M$2.98M$14.80M$14.50M$13.60M$12.90M$12.98M$12.60M$11.70M$10.40M
Low Forecast$2.41M$2.98M$14.80M$14.50M$13.60M$12.90M$11.82M$12.60M$11.70M$10.40M
# Analysts1111111111
Surprise %---0.54%0.63%0.76%0.91%0.95%0.99%1.06%

Healthcare Triangle's average Quarter revenue forecast for Dec 23 based on 1 analysts is $14.80M, with a low forecast of $14.80M, and a high forecast of $14.80M. HCTI's average Quarter revenue forecast represents a 90.26% increase compared to the company's last Quarter revenue of $7.78M (Sep 23).

Healthcare Triangle EBITDA Forecast

Sep 24Jun 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22
# Analysts1111111111
EBITDA---$-812.00K$-1.18M$-2.33M$-3.85M$-1.34M$-589.00K$-1.26M
Avg Forecast$-104.67K$-129.44K$-641.98K$-628.96K$-589.92K$-559.56K$-537.87K$-606.83K$-563.48K$-1.26M
High Forecast$-104.67K$-129.44K$-641.98K$-628.96K$-589.92K$-559.56K$-512.72K$-606.83K$-563.48K$-1.01M
Low Forecast$-104.67K$-129.44K$-641.98K$-628.96K$-589.92K$-559.56K$-563.03K$-606.83K$-563.48K$-1.52M
Surprise %---1.29%1.99%4.17%7.16%2.20%1.05%1.00%

undefined analysts predict HCTI's average Quarter EBITDA for undefined to be $NaN, with a high of $NaN and a low of $NaN. This is NaN% lower than Healthcare Triangle's previous annual EBITDA (undefined) of $NaN.

Healthcare Triangle Net Income Forecast

Sep 24Jun 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22
# Analysts1111111111
Net Income---$-1.94M$-1.79M$-3.28M$-4.86M$-2.34M$-405.00K$-2.01M
Avg Forecast$8.73M$7.14M$-1.13M$-1.70M$-1.70M$-2.27M$-2.27M$-2.13M$-2.66M$-2.01M
High Forecast$8.73M$7.14M$-1.13M$-1.70M$-1.70M$-2.27M$-2.27M$-2.13M$-2.66M$-1.61M
Low Forecast$8.73M$7.14M$-1.13M$-1.70M$-1.70M$-2.27M$-2.27M$-2.13M$-2.66M$-2.41M
Surprise %---1.14%1.05%1.45%2.15%1.10%0.15%1.00%

Healthcare Triangle's average Quarter net income forecast for undefined is $NaN, with a range of $NaN to $NaN. HCTI's average Quarter net income forecast represents a NaN% decrease compared to the company's last Quarter net income of $NaN (undefined).

Healthcare Triangle SG&A Forecast

Sep 24Jun 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22
# Analysts1111111111
SG&A---$2.46M$2.64M$3.39M$2.90M$3.29M$3.10M$3.09M
Avg Forecast$517.88K$640.42K$3.18M$3.11M$2.92M$2.77M$2.66M$2.70M$2.51M$3.09M
High Forecast$517.88K$640.42K$3.18M$3.11M$2.92M$2.77M$2.79M$2.70M$2.51M$3.71M
Low Forecast$517.88K$640.42K$3.18M$3.11M$2.92M$2.77M$2.54M$2.70M$2.51M$2.47M
Surprise %---0.79%0.90%1.22%1.09%1.22%1.24%1.00%

Healthcare Triangle's average Quarter SG&A projection for Dec 23 is $3.18M, based on 1 Wall Street analysts, with a range of $3.18M to $3.18M. The forecast indicates a 28.86% rise compared to HCTI last annual SG&A of $2.46M (Sep 23).

Healthcare Triangle EPS Forecast

Sep 24Jun 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22
# Analysts1111111111
EPS---$-0.46$-0.00$-0.08$-0.13$-0.06$-0.01$-0.06
Avg Forecast$1.54$1.34$-0.20$-0.30$-0.30$-0.40$-0.40$-0.40$-0.50$-0.50
High Forecast$1.54$1.34$-0.20$-0.30$-0.30$-0.40$-0.40$-0.40$-0.50$-0.50
Low Forecast$1.54$1.34$-0.20$-0.30$-0.30$-0.40$-0.40$-0.40$-0.50$-0.50
Surprise %---1.53%0.00%0.20%0.33%0.16%0.02%0.11%

According to undefined Wall Street analysts, Healthcare Triangle's projected average Quarter EPS for undefined is $NaN, with a low estimate of $NaN and a high estimate of $NaN. This represents a NaN% decrease compared to HCTI previous annual EPS of $NaN (undefined).

Healthcare Triangle Peer Comparison by Price Target


TickerCompanyLast Closing PriceAvg Price TargetUpside/DownsideAvg Rating
CMAXCareMax$0.67$2.60288.06%Hold
HCTIHealthcare Triangle$1.07$2.0086.92%Buy
MPLNMultiPlan$7.02$10.0042.45%Hold
UTRSMinerva Surgical-$5.00-Buy

HCTI Forecast FAQ


Is Healthcare Triangle a good buy?

Yes, according to 1 Wall Street analysts, Healthcare Triangle (HCTI) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 1 'Buy' recommendations, accounting for 100.00% of HCTI's total ratings.

Did the HCTI's actual financial results beat the analysts' financial forecasts?

Based on Healthcare Triangle's last annual report (Dec 2023), the company's revenue was $33.2M, which missed the average analysts forecast of $55.8M by -40.50%. Apple's EBITDA was $-6.11M, beating the average prediction of $-2.42M by 152.43%. The company's net income was $-12.339M, beating the average estimation of $-6.799M by 81.47%. Apple's SG&A was $10.09M, missing the average forecast of $11.98M by -15.71%. Lastly, the company's EPS was $-0.0029, missing the average prediction of $-1.2 by -99.76%. In terms of the last quarterly report (Sep 2023), Healthcare Triangle's revenue was $7.78M, missing the average analysts' forecast of $14.5M by -46.35%. The company's EBITDA was $-812K, beating the average prediction of $-629K by 29.10%. Healthcare Triangle's net income was $-1.943M, beating the average estimation of $-1.7M by 14.30%. The company's SG&A was $2.46M, missing the average forecast of $3.11M by -20.79%. Lastly, the company's EPS was $-0.46, beating the average prediction of $-0.3 by 53.33%